LZI Cotinine II Enzyme Immunoassay— 510(k) K192299

Substantially Equivalent

Lin-Zhi International, Inc.

FDA 510(k) clearance K192299 for LZI Cotinine II Enzyme Immunoassay, Substantially Equivalent on 2019-11-21. Applicant: Lin-Zhi International, Inc..

Clearance details

Applicant
Lin-Zhi International, Inc.
Product code
Code MKU
Advisory panel
Clinical Toxicology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Santa Clara, CA, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.